CompoAtlas

Triflex

Natural health product licensed in Canada

Other names
Glucosamine chondroitin MSM
Licence holder
GNC Canada Holdings ULC
NPN or DIN-HM
80004453
Status
Inactive licence
Licence date
7 November 2007
Revision date
26 March 2012
Form
Caplet
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
2-Amino-2-deoxy-D-glucose hydrochloride

Source : Exosquelette de crustacés

500 mgNot calculated

Non-medicinal ingredients

Hypromellose, Eau, Cire de Carnauba, Poly(éthylène glycol), Cellulose - microcrystalline, Croscarmellose de sodium, Stéarate de magnésium végétal, Dioxyde de silicium

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Caplet3 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps to relieve joint pain associated with osteoarthritis. Helps to relieve the pain associated with osteoarthritis of the knees. A factor in maintaining healthy cartilage. Helps to maintain healthy cartilage. A factor in maintaining joint health. Helps to maintain joint health.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80004453

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2012. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.

List recorded in 2012. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line